Firebrick Pharma Limited (ASX:FRE) Financings
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Private placement of securities Announced: private placement | Nov 11, 2026 | |
| Strategic investment of ordinary fully paid shares Closed: A$732,000 raised · A$0.035 a share Buyers: Pharma Nutria N.A. Inc. ($631,750, increasing its holding in Firebrick to just over 10.0%) Use of proceeds: New production for US retail distribution, production and launch in Singapore of a new Nasodine product, and working capital | Oct 18, 2026 | US$510,774 |
| Private placement of securities Announced: private placement | Oct 11, 2026 |